摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-morpholino-1-(naphthalen-2-yl)-2-thioxoethanone | 1033590-39-4

中文名称
——
中文别名
——
英文名称
2-morpholino-1-(naphthalen-2-yl)-2-thioxoethanone
英文别名
2-morpholino-1-(naphthalen-2-yl)-2-thioxoethan-1-one;2-Morpholin-4-yl-1-naphthalen-2-yl-2-sulfanylideneethanone;2-morpholin-4-yl-1-naphthalen-2-yl-2-sulfanylideneethanone
2-morpholino-1-(naphthalen-2-yl)-2-thioxoethanone化学式
CAS
1033590-39-4
化学式
C16H15NO2S
mdl
——
分子量
285.367
InChiKey
HDZBOMBTWROETN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    156-158 °C
  • 沸点:
    460.4±55.0 °C(Predicted)
  • 密度:
    1.289±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    61.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Selective reduction of carbonyl groups in the presence of low-valent titanium reagents
    作者:Wei Lin、Ming-Hua Hu、Xian Feng、Lei Fu、Cheng-Pao Cao、Zhi-Bin Huang、Da-Qing Shi
    DOI:10.1016/j.tetlet.2014.02.072
    日期:2014.4
    The chemoselective reduction of several structurally diverse compounds containing carbonyl groups was achieved in the presence of low-valent titanium reagents. This novel synthetic method provides easy access to highly selective reduction of carbonyl groups, and possesses several advantages including one-step procedure, convenient manipulation, good to excellent yields, and short reaction times.
    在低价钛试剂的存在下,实现了几种含有羰基的结构多样的化合物的化学选择性还原。这种新颖的合成方法易于获得羰基的高选择性还原,并具有多个优点,包括一步法,方便的操作,良好或优异的收率以及较短的反应时间。
  • Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
    作者:Quentin Spillier、Séverine Ravez、Judith Unterlass、Cyril Corbet、Charline Degavre、Olivier Feron、Raphaël Frédérick
    DOI:10.3390/ph13020020
    日期:——
    synthetic pathway, and particularly of the phosphoglycerate dehydrogenase (PHGDH), the first enzyme of the pathway, to sustain cancer progression. Yet, because of very weak potencies usually in cell-based settings, the inhibitors reported so far failed to lay ground on the potential of this approach. In this paper, we report a structure-activity relationship study of a series of α-ketothioamides that we
    多年来,靶向癌细胞代谢中的失调已成为开发更具体和有效的癌症治疗方法的有希望的战略。最近,许多报道强调了丝氨酸合成途径,特别是磷酸甘油酸脱氢酶(PHGDH)(该途径的第一种酶)在维持癌症进展中的关键作用。但是,由于通常在基于细胞的环境中效能很弱,因此迄今为止报道的抑制剂未能为这种方法的潜力奠定基础。在本文中,我们报告了我们最近鉴定出的一系列α-酮硫代酰胺的构效关系研究。有趣的是,该研究导致对该系列中的结构-活性关系(SAR)有了更深入的了解,并鉴定了新的PHGDH抑制剂。通过细胞热位移测定和基于细胞的实验证实了更有效的化合物的活性。我们希望这项研究最终将基于这种有前途的化学支架,为开发靶向PHGDH的治疗药物提供新的切入点。
  • Direct synthesis of α-ketothioamides from aryl methyl ketones and amines via I2-promoted sp3 C–H functionalization
    作者:Hong-Zheng Li、Wei-Jian Xue、An-Xin Wu
    DOI:10.1016/j.tet.2014.05.045
    日期:2014.8
    A domino reaction that involves the formation of CS and C–N bonds in one process via sp3 C–H functionalization strategy has been developed. This reaction affords an efficient and direct method for the synthesis of α-ketothioamides from aryl methyl ketones, amines, and sodium hydrosulfide under the promotion of iodine.
    已经开发了一种通过sp 3 C–H官能化策略在一个过程中形成C S和C–N键的多米诺反应。该反应提供了在碘的促进下由芳基甲基酮,胺和氢硫化钠合成α-酮硫代酰胺的有效而直接的方法。
  • METHOD FOR MANUFACTURING AROMATIC NITRILE COMPOUND
    申请人:API CORPORATION
    公开号:US20210078940A1
    公开(公告)日:2021-03-18
    The present invention provides a method for industrially producing a highly pure aromatic nitrile compound and a highly pure aromatic carboxylic acid compound safely and highly efficiently at low costs. Compound (2) is subjected to Willgerodt reaction in the presence of an additive as necessary, and the obtained amide compound (3) is hydrolyzed and neutralized to give carboxylic acid compound (4). Carboxylic acid compound (4) is reacted with a halogenating agent in the presence of a catalyst as necessary in an organic solvent, and further reacted with an amidating agent, and the obtained amide compound (5) or (6) is reacted with a dehydrating agent to give nitrile compound (1). Alternatively, carboxylic acid compound (4) is reacted with a halogenating agent and a compound represented by the formula R 6 SO 2 R 7 in the presence of a catalyst as necessary in an organic solvent to give nitrile compound (1). Np is a naphthyl group optionally having substituent(s), R 5 is an alkylene group having 1-3 carbon atoms, and other symbols are as described in the DESCRIPTION.
    本发明提供了一种低成本、高纯度、安全高效地工业生产高纯度芳香基腈化合物和高纯度芳香基羧酸化合物的方法。化合物(2)在必要的添加剂存在下经过威尔格罗德反应,得到酰胺化合物(3),然后将酰胺化合物(3)水解并中和,得到羧酸化合物(4)。在有机溶剂中,羧酸化合物(4)在必要的催化剂存在下与卤代试剂反应,进一步与酰胺化试剂反应,得到酰胺化合物(5)或(6),然后与脱水试剂反应,得到腈化合物(1)。或者,羧酸化合物(4)在必要的催化剂存在下与卤代试剂和式为R6SO2R7的化合物反应,得到腈化合物(1)。其中,Np是一个萘基,可选地具有取代基,R5是一个具有1-3个碳原子的烷基,其他符号如描述中所述。
  • [EN] SERINE BIOSYNTHETIC PATHWAY INHIBITORS<br/>[FR] INHIBITEURS DE LA VOIE DE BIOSYNTHÈSE DE LA SÉRINE
    申请人:UNIV CATHOLIQUE LOUVAIN
    公开号:WO2017157882A1
    公开(公告)日:2017-09-21
    The present invention relates to a compound of formula (I), a stereoisomer thereof, an enantiomer thereof, a racemic thereof, or a tautomer thereof as defined in claim 1 (I) the present invention also relates to a compound of formula (I), a stereoisomer thereof, an 5 enantiomer thereof, a racemic thereof, or a tautomer thereof, as defined in the claims for use as a medicament, in particular for use in the prevention or treatment of a cellular proliferative disease.
    本发明涉及公式(I)的化合物,其立体异构体,对映异构体,消旋体或互变异构体,如权利要求1中定义的(I)。本发明还涉及公式(I)的化合物,其立体异构体,对映异构体,消旋体或互变异构体,如权利要求中定义的用作药物,特别是用于预防或治疗细胞增殖性疾病。
查看更多